MING-SHIANG WUCHIA-TUNG SHUNWEN-CHUNG LEEChen C.-J.HSIU-PO WANGWEN-JENG LEEJIN-CHUAN SHEULin J.-T.2020-08-052020-08-0519980007-0920https://scholars.lib.ntu.edu.tw/handle/123456789/511081p53 immunostaining was evaluated in cancerous epithelia and adjacent intestinal metaplasia of 135 gastric cancer specimens. The differential p53 overexpression in different subtypes of intestinal metaplasia and gastric cancer suggests that type III intestinal metaplasia is the commonest lesion in dysplasia-carcinoma transition, particularly in the intestinal type of gastric cancer.[SDGs]SDG3protein p53; article; human; human tissue; immunohistochemistry; intestine metaplasia; major clinical study; priority journal; stomach cancerjournal article10.1038/bjc.1998.61197645932-s2.0-0031708995